BAX Baxter International PE ratio, current and historical analysis
- Stocks
- Healthcare
- NYSE: BAX
- PE Ratio
The current PE ratio of BAX can't be determined, as the TTM EPS of -$1.1 is negative. The last recorded PE ratio for Baxter International was 180.81 in September 2024.
BAX PE ratio history
The average historical PE ratio of Baxter International for the last ten years is 32.35. In the past ten years, BAX's PE ratio was at its highest in the Sep 2024 quarter at 180.81, when the stock price was $37.97 and the EPS was $0.21. The lowest value was in the Dec 2016 quarter, when it reached 4.88 with a price of $44.34 and an EPS of $9.09.
Baxter International PE ratio by year
Maximum annual increase: 1,093.24% in 2017
Maximum annual decrease: -77.23% in 2016
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | N/A | N/A | $29.16 | -$1.27 |
| 2023 | 7.36 | N/A | $38.66 | $5.25 |
| 2022 | N/A | N/A | $50.97 | -$4.83 |
| 2021 | 33.53 | -9.33% | $85.84 | $2.56 |
| 2020 | 36.98 | -12.89% | $80.24 | $2.17 |
| 2019 | 42.45 | 87% | $83.62 | $1.97 |
| 2018 | 22.7 | -61.02% | $65.82 | $2.9 |
| 2017 | 58.23 | 1,093.24% | $64.64 | $1.11 |
| 2016 | 4.88 | -77.23% | $44.34 | $9.09 |
| 2015 | 21.43 | 34.78% | $38.15 | $1.78 |
| 2014 | 15.9 | -15.43% | $73.29 | $4.61 |
| 2013 | 18.8 | 18.99% | $69.55 | $3.7 |
| 2012 | 15.8 | 24.9% | $66.66 | $4.22 |
| 2011 | 12.65 | -39.76% | $49.48 | $3.91 |
| 2010 | 21 | 29.87% | $50.62 | $2.41 |
Baxter International PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2025 | N/A | N/A | $34.23 | -$1.1 |
| Dec 2024 | N/A | N/A | $29.16 | -$1.27 |
| Sep 2024 | 180.81 | 2,543.42% | $37.97 | $0.21 |
| Jun 2024 | 6.84 | -16.28% | $33.45 | $4.89 |
| Mar 2024 | 8.17 | 11.01% | $42.74 | $5.23 |
| Dec 2023 | 7.36 | 0% | $38.66 | $5.25 |
| Sep 2023 | 7.36 | N/A | $37.74 | $5.13 |
| Jun 2023 | N/A | N/A | $45.56 | -$5.65 |
| Mar 2023 | N/A | N/A | $40.56 | -$4.87 |
| Dec 2022 | N/A | N/A | $50.97 | -$4.83 |
| Sep 2022 | N/A | N/A | $53.86 | -$4.71 |
| Jun 2022 | 31.8 | -13.47% | $64.23 | $2.02 |
| Mar 2022 | 36.75 | 9.6% | $77.54 | $2.11 |
| Dec 2021 | 33.53 | 0.87% | $85.84 | $2.56 |
| Sep 2021 | 33.24 | -8.33% | $80.43 | $2.42 |
BAX Price vs fair value
BAX average PE ratio chart
BAX PE vs peers
| Stock name | PE ratio | Market cap |
|---|---|---|
| HALO Halozyme Therapeutics Inc | 13.95 | $6.62B |
| TMO Thermo Fisher Scientific Inc | 23.77 | $153.37B |
| CAH Cardinal Health Inc | 23.9 | $36.73B |
| MDT Medtronic plc | 26.34 | $111.82B |
| BDX Becton Dickinson & Co | 33.32 | $49.47B |
| SYK Stryker Corp | 51.47 | $147.52B |
| BSX Boston Scientific Corp | 74.13 | $151.35B |
| OMI Owens & Minor Inc | N/A | $604.49M |
| ICUI Icu Medical Inc | N/A | $3.26B |
| BAX Baxter International Inc | N/A | $15.48B |
Frequently asked questions
What is Baxter International's PE ratio?
The current price to earnings ratio of BAX can't be calculated, as its EPS of -$1.1 is negative.
What is the 3-year average PE ratio for Baxter International (BAX)?
As an average over the last 3 years, BAX stock has a PE ratio of 40.39.
What is the 5-year average PE ratio for Baxter International (BAX)?
As an average over the last 5 years, BAX stock has a PE ratio of 39.4.
What is the highest PE ratio for BAX?
The highest quarterly PE ratio in the last ten years has been 180.81 and it was in the Sep 2024 quarter.
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.